Secondary malignant neoplasm
MONDO:0024881A malignant neoplasm that arises from a pre-existing lower grade lesion, or as a result of a primary lesion that has spread to secondary sites, or due to a complication of a cancer treatment.
Also known as: secondary cancer, secondary malignancy, secondary malignant neoplasm
3808 clinical trials for this condition and its sub-types, 27 tagged with Secondary malignant neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Secondary malignant neoplasm
-
Metastatic malignant neoplasm 748 trials · 1,264 incl. sub-types
7 sub-types
- Metastatic malignant neoplasm in the brain 266 trials
- Metastatic carcinoma 22 trials · 168 incl. sub-types Sub-types →
- Neoplastic meningitis 82 trials
- Metastatic malignant neoplasm in the spinal cord 38 trials
- Metastasis from malignant tumor of colon 27 trials
- Metastatic malignant neoplasm in the colon 18 trials
- Metastatic malignant neoplasm in the eye 1 trial
-
Secondary carcinoma 1 trial · 169 incl. sub-types
1 sub-type
- Metastatic carcinoma 22 trials · 168 incl. sub-types Sub-types →
Most studied deeper sub-types
-
Organ transplant may offer new hope for rare abdominal cancer patients
Disease control Not yet recruitingThis study tests whether an intestinal or multivisceral transplant can help people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that cannot be removed by surgery. Twenty participants will receive the transplant and be followed for 12 months to see if they surv…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Robot-Guided radiation aims to shrink kidney tumors with fewer side effects
Disease control Not yet recruitingThis study tests a highly precise type of radiation called SBRT for people with kidney cancer who cannot undergo surgery. The treatment uses a robotic system (CyberKnife) to deliver high-dose radiation directly to the tumor while sparing healthy tissue. Researchers will track 60 …
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New program aims to catch late effects in childhood cancer survivors
Disease control Not yet recruitingThis trial tests a program called ONLOOP that reminds adult survivors of childhood cancer to get important screening tests. These tests can find late effects like heart disease or second cancers early. About 900 survivors in Ontario will be randomly assigned to get the reminders …
Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a supplement beat cancer fatigue? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether a dietary supplement called Redsenol-1 Plus can safely reduce fatigue in adults who have had cancer treatment. 72 participants will take either the supplement or a placebo for 12 weeks. The main goal is to see if fatigue levels improve, as measured by a s…
Sponsor: Canada Royal Enoch Phytomedicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can exercise help cancer patients? new study aims to find out
Knowledge-focused Not yet recruitingThis study will survey 370 adult cancer patients about their knowledge, attitudes, and practices regarding physical exercise. The goal is to understand why many patients don't exercise enough and what barriers they face. Results will help create better exercise programs and possi…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Liver surgery showdown: 15 vs 45 minutes of clamping – which is safer?
Knowledge-focused Not yet recruitingThis study looks at two different lengths of time for stopping blood flow to the liver during surgery for liver cancer. 600 adults will be randomly assigned to either a 15-minute or 45-minute pause in blood flow. The goal is to see if the longer pause is just as safe and does not…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC